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The effects of nanodispersed iron forms on the morphology and function of the blood sys­
tem were studied. Maghemite and lepidocrocite caused a leukocytic shift towards segmented 
neutrophil forms, reduction of lymphocyte rigidity, and stimulated their compactization. In 
addition, the counts of small hyperchromatic erythrocytes with high rigidity increased in the 
blood flow. The results indicated that a single dose of nanodispersed iron-containing drugs 
improved the blood respiratory function and its microrheology.
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The biological and toxic characteristics of nanosized 
objects are determined by their dispersion, physico­
chemical and structural parameters [5]. Interactions 
between nanoparticles of different chemical composi­
tion and structure and biological objects have been 
studied [7]. Metal oxide nanoparticles are characteri­
zed by cytotoxic, embryotoxic, and teratogenic effects 
[6], they accumulate in lymphoid tissue and cause 
DNA aberrations [1], disorder the blood clotting sys­
tem work [3]. The toxicity of nanomaterials depends 
on their physical nature, method of preparations, size, 
structure of nanoparticles, and on the biological model 
on which the trials are carried out. Importantly that the 
nanomaterials do not always exhibit toxic or destruc­
tive effects [4], and hence, the development of tests for 
evaluation of the nanomaterials toxicity is in progress.
We have studied the effects of nanodispersed iron 
forms on the morphofunctional parameters of erythro­
cytes and leukocytes.
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MATERIALS AND METHODS
Experimental studies were carried out at Laborato­
ry of Adaptation Processes Physiology of Belgorod 
State National Research University. Iron-containing 
nanodispersed preparations were used: maghemite 
(g-Fe2O3), lepidocrocite (g-FeOOH), and solution 
containing iron ions. Nanodispersed maghemite form 
consisted of nanotubules 100 nm long and 10 nm in 
diameter, with 2-3-nm channels inside the tubules. 
Lepidocrocite nanoparticles were cylindrical nanorods 
100-150 nm long and 5-8 nm in diameter. Iron ion- 
containing solution was prepared from Mohr’s salt 
(NH4)2Fe(SO4)2'6H2O, chemically pure. The concen­
tration of iron ions in the solution was 0.25 mmol/liter.
Biological activity of iron-containing preparations 
was evaluated on adult outbred laboratory male rats 
(n=24). The study was carried out in accordance with 
the regulations of the Helsinki Declaration on Humane 
Handling of Animals and Directives of the EEC on the 
Protection of Animals Used with Experimental and 
Other Research Purposes. The animals were kept on
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standard rations; nutrition, temperature, and humidity 
were the same for all animals. Group 1 («=6) were 
controls. Animals of groups 2, 3, and 4 (6 per group) 
received a single intragastric (through a tube) dose 
(1 ml) of g-Fe2O3, g-FeOOH nanoparticles, or Mohr’s 
salt, respectively. The concentrations of maghemite 
and lepidocrocite nanoparticles was 100 mg/ml, of 
iron ions in solution 0.25 mmol/liter. Before admin­
istration, the suspensions were processed in Sapfir 
USV-1.3 TTZ ultrasonic bath (10 min) for destruction 
of the nanoparticles agglomerates. Controls received 
1 ml water.
Blood was collected by decapitation of narco­
tized animals 24 h after administration of the studied 
substances. Heparin (20 U/ml) served as the antico­
agulant. Smears from whole blood were prepared for 
evaluation o f the differential leukocytic count and 
stained after Romanowskii-Giemsa. Erythrocyte and 
leukocyte populations were isolated by blood centrifu­
gation (10 min, 1500 rpm). The leukocyte ring was 
collected. Erythrocytes were washed and resuspended 
in isotonic buffer. Erythrocytes were counted in Go­
ryaev’s chamber for all animals, hemoglobin concen­
tration was measured by photocolorimetry, and hema­
tocrit was evaluated after whole blood centrifugation 
on a hematocrit centrifuge. Smears for atomic force 
microscopy were made from the resultant leukocyte 
and erythrocyte suspensions. Scanning was carried 
out in a humid box in the semicontact mode using sili­
con probes (lot NSG03 (NT-MDT), 1.1 H/m rigidity, 
rounding radius 10 nm, scanning resolution frequency 
0.6-0.8 Hz). Cell diameter, height, and volume were 
measured in the resultant scans. The results were pro­
cessed using Nova 1.0.26 Build 1397 software (NT- 
MDT Company). The effects of nanodispersed iron- 
containing preparations on the elastic properties of 
formed elements of the blood were studied by atomic 
force spectroscopy by load application to local sites 
of the cell surface.
Plasma iron content in control and two experi­
mental groups (maghemite and soluble iron) was mea­
sured by X-ray spectrochemical analysis. The studies 
were carried out on an ARL Optim X X-ray fluores­
cent spectrometer at Center for Common Equipment
TABLE 1. Blood System Morphology and Function
Parameter Control Maghemite Lepidocrocite
Leukocyte count, 109 liter-1 3.6±0.6 3.00±0.35 2.80±0.15
Monocytes, % 1.8±0.6 1.7±0.3 -
Eosinophils, % 1.3±0.2 0.70±0.08* -
Young neutrophils, % 2.5±0.3 0.90±0.01* 1.000±0.001*
Stab neutrophils, % 16.9±0.6 16.3±0.2 13.80±0.08*
Segmented neutrophils, % 17.4±0.3 24.4±1.5* 21.5±1.0*
Lymphocyte diameter, ц 7.50±0.08 7.30±0.08 6.90±0.07
Lymphocyte height, ц 1.40±0.04 1.40±0.01 1.60±0.02*
Lymphocyte surface area, ц2 44.40±0.98 41.90±0.04 38.20±0.81*
Lymphocyte volume, ц3 60.5±1.5 55.6±0.7 58.7±1.2
Lymphocyte rigidity, Pa 16.9±0.7 14.8±0.6* 14.3±0.5*
Erythrocyte count, 1012 liter-1 7.50±0.24 6.800±0.005* 6.30±0.11*
Hemoglobin concentration, g /lite r 145.3±3.7 230.1±8.0* 235.2±2.6*
Hematocrit, % 36.00±0.01 37.00±0.01 35.00±0.01
Mean hemoglobin concentration in 
erythrocyte, pg 20.1±3.6 33.54±0.90* 37.5±2.5*
Erythrocyte diameter, ц 5.80±0.07 5.70±0.04 5.60±0.06
Erythrocyte height, ц 0.50±0.01 0.40±0.01* 0.50±0.01
Erythrocyte volume, ц3 30.5±1.4 23.5±1.1* 30.6±1.5
Erythrocyte surface area, ц2 52.2±8.7 40.3±6.5* 52.2±2.7
Erythrocyte rigidity, Pa 17.6±2.5 22.5±1.2* 19.9±1.0*
Note. *p<0.05 in comparison with the control.
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Exploitation of the University. The results were statis­
tically processed, the significance of differences was 
evaluated by Student’s t test.
RESULTS
A single oral dose of iron-containing drugs led to an 
increase of plasma concentration of iron atoms, by 
86% (p<0.05) in response to Mohr’s salt and by 43% 
(p<0.05) in response to maghemite.
The differential leukocytic count in experimental 
animals was shifted towards mature segmented neutro­
phils, the counts of eosinophils decreased. The levels 
of segmented neutrophils increased by 40 and 23.5% 
(p<0.05) in response to maghemite and lepidocrocite, 
respectively, while the levels of young neutrophils 
decreased by 36 and 40% (p<0.05) in comparison with 
the control (Table 1). Nanodispersed iron-containing 
drugs caused no changes in the total leukocyte count. 
The lymphocyte morphometric parameters changed 
under the effects of nanodispersed iron forms. Lym­
phocyte height increased by 10% (p<0.05) and their 
surface area decreased by 14% (p<0.05) in the lepido­
crocite group in comparison with the control. Soluble 
iron (Mohr’s salt) led to a reduction of the lymphocyte 
diameter and surface area by 13 and 28%, respec­
tively (p<0.05), while the cell height increased by 11% 
(p<0.05) in comparison with the control. Lymphocyte 
rigidity decreased by 14.8 and 18.18% (p<0.05) in 
response to iron nanoparticles and soluble iron, respec­
tively, in comparison with the control.
Total erythrocyte counts decreased in response 
to maghemite and lepidocrocite by 10 and 19%, re­
spectively (p<0.05), while hemoglobin concentration 
increased by 58.4 and 62% (p<0.05) in comparison 
with the control. Maghemite caused a decrease in the 
erythrocyte height, volume, and surface area by 12, 
23, and 23% (p<0.05), respectively, in comparison 
with the control (Table 1). Lepidocrocite exhibited no 
appreciable effect on the erythrocyte morphometric 
parameters. On the whole, the reaction of the blood 
erythroid component to iron nanoparticles was aimed 
at cell shrinkage and was paralleled by changes in the 
functional characteristics of erythrocytes. This mani­
fested by an increase of hemoglobin concentration in 
the erythrocyte to 33.5±0.9 pg in the maghemite group 
and to 37.5±2.5 pg in the lepidocrocite group, this 
involving an increase of oxygen capacity of the blood 
by 58.4 and 50% (p<0.05), respectively, in comparison 
with the control. Interestingly, erythrocyte diameter
and hematocrit virtually did not differ in experimental 
and control groups. Erythrocyte elasticity increased 
under the effect of iron nanoparticles by 28% (p<0.05) 
in response to maghemite and by 13% (p<0.05) in 
response to lepidocrocite.
Hence, a single dose of nanodispersed iron-con­
taining drugs enhanced phagocytosis by increasing 
the counts of mature segmented forms and reducing 
the percentage of young neutrophils, presumably by 
accelerating their maturing. In addition, reduction of 
lymphocyte rigidity under the effects of nanoparticles 
and soluble iron forms improved the blood rheology. 
Pathomorphologic findings indicated that a single dose 
of nanosized iron of about 250 mg/kg was nontoxic for 
organs and tissues; on the other hand, this substance 
led to stimulation of immune reactions [2].
Nanodispersed iron forms improved the respira­
tory function of the blood, modulating the geometrical 
profile of erythrocytes and their hemoglobin satura­
tion. Presumably, the appearance of hyperchromatic 
erythrocytes of small size was explained by trigger­
ing of redistribution reactions in the system, aimed 
at the maintenance of oxygen homeostasis. Specifi­
cally, the geometrical profile and hemoglobin content 
in each erythrocyte play the key role in oxygenation 
processes: the smaller the erythrocyte, the more rapid 
is oxygen consumption by hemoglobin in the lungs. 
Hyperchromatic erythrocytes of experimental rats 
maintained the oxygen-transporting function of the 
blood under conditions of reduced erythrocyte counts, 
thus improving blood rheology. On the other hand, the 
increase of erythrocyte rigidity in experimental groups 
indicated adsorption and transport of nanodispersed 
iron forms on erythrocyte surface.
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